Disposable Plastic Blood Bags Market Size and Share Analysis Report by Type (Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags), End User (Hospitals, NGOs, Blood Banks, Home Healthcare), Distribution Channel (Tender Sales, Private Sales) - Global Industry Demand Forecast to 2030

Market Overview

The global disposable plastic blood bags market size in 2021 was $310.5 million, and it is expected to advance at a CAGR of 6.1% during 2021–2030, to reach $530.0 million by 2030. Apart from blood, they aid in the separation of RBCs, WBCs, platelets, plasma, and cryoprecipitate, to treat a variety of disorders, which is why their sales continue to burgeon around the world.

The market is expanding rapidly as a result of the rising chronic disease prevalence and an aging population. Furthermore, the initiatives of government associations to raise blood donation awareness and use of RFID are propelling the global expansion. Additionally, opportunities are coming out of Asian countries, such as India and China, which are advocating the use of these bags for the collection and storage of blood. Furthermore, the industry is driven by the rising frequency of severe accidents and major injuries around the world, which often lead to hypovolemic shock.

Global Scenario

The presence of a large number of participants is creating an intense competition in the market. International and regional vendors have a broad geographical footprint and product penetration, and they are increasingly concentrating on broadening their user base and product offerings. Conversely, the enormous untapped market potential in emerging economies, such as China and India, is likely to provide participants with attractive opportunities. This is linked to the availability of low-cost medical treatments for a variety of diseases in these.

Furthermore, due to the increasing prevalence of chronic diseases and the aging population, there are more consumers in the industry, which decrease their bargaining power. The sector has a modest number of suppliers, which results in a moderate level of supplier negotiating power. The danger of forward integration posed by raw material suppliers also has an impact on suppliers' negotiating leverage. The approval of disposable plastic blood bags is subject to tight regulations and drawn-out processes, so raw material suppliers would not rush to invest in their production. Consequently, suppliers' bargaining power would increase.

Additionally, buyers are less likely to consider substitutes because these bags are both safer and less expensive than glass bottles. The minimal degree of product differentiation among existing players intensifies the competition further. In order to acquire high revenue, manufacturers are attempting to create highly effective variants at a low cost. Any new disposable plastic bag manufacturer must adhere to stringent regulations on medical device safety. However, the lower capital requirement than many other complicated medical devices creates an opportunity for new participants.

Single Disposable Plastic Blood Bag Is Generating Highest Revenue

Single disposable plastic blood bag was the highest revenue contributor in 2021. This is a result of an increase in the volume of transfusion procedures, rise in trauma and accident cases, and surge in the prevalence of numerous hematologic illnesses.

Disposable Blood Bags Are Extensively Used in Hospitals

Hospitals are the largest users of these bags, with a revenue share of more than 60% in 2021. These bags are used for blood collection and transfusion in hospitals due to their many beneficial qualities and biocompatibility traits. The need for blood supply in hospitals has increased due to the rising prevalence of chronic diseases, such as cancer, as well as the surging number of surgical procedures.

These factors have also contributed to the expansion of the healthcare industry and the rise in the number of hospitals and health clinics. The bags offer a secure environment for the storage and transportation of blood and its constituents.

The contribution of blood banks is expanding steadily, as they dedicatedly gather and give blood and its components to those who require it. These institutions work to maximize the timely delivery of this product from the appropriate donors to the appropriate patients. Having a suitable inventory on hand at all times is the simplest way to ensure a timely supply of blood. Additionally, these banks make use of RFID tags and compatible software to track & trace the supply.

Services that are offered at home are included in home healthcare. These services are more affordable and allow for flexible treatment. Home care is availed for illnesses that call for frequent intravenous infusions and injections, to save money on repetitive hospital visits. Products such as blood bags, syringes, and IV sets are frequently used at home for this purpose. Nurses with appropriate training transfuse blood using disposable bags. The same safety regulations apply to home-based services as they do to hospital transfusions. Additionally, due to the isolation steps taken during the pandemic, many patients with chronic diseases used this service.

Explore more about this report - Request free sample

Tender-Based Sales Contributing Majorly to Market Revenue

Disposable plastic blood bags market sales are mostly conducted through the tender-based channel. Manufacturers' strategies must include sales through tenders in the healthcare sector. Through a competitive bidding process, a tender assists in the bulk procurement of products and services. Tender-based purchases are frequently used to reduce the cost throughout the course of a contract. Because of the price competition, the adoption of this method to lower the cost would rise. In addition to reducing some of the inefficiencies brought on by segmented distribution systems, it frequently generates economies of scale.

Blood bag bidding is a widespread practice in both industrialized and developing nations. The growing health coverage in important economies, such as China, Brazil, and Russia, will probably increase the demand for public contracting and cost-cutting techniques, primarily tendering. The industry is also growing as a result of the blood donation initiatives launched by various government agencies and non-profit organizations.

Sales to private healthcare institutions will keep growing over the projection period. This is a result of the increasing donation efforts by private organizations, a high prevalence of various chronic medical conditions, and an increase in the count of traffic accidents. Additionally, the advance of this sector is being fueled by the expansion of the healthcare infrastructure and setup of blood banks in private hospitals, medical research labs, and diagnostic centers.

Regional Insights

During the projection period, North America is expected to maintain its dominance around the globe. The surging penetration of pathological and hematological tests, as well as the region's high prevalence of chronic diseases, provides lucrative growth opportunities.

Furthermore, the presence of a well-equipped healthcare infrastructure, increasing donation activities, and government attempts to promote the use of these bags to prevent hospital-acquired infections, which are a major risk with glass bottles, positively impact the growth. In addition, the presence of significant manufacturers in the region adds to the revenue. Because of the increasing prevalence of long-term disorders, the U.S. is the larger market in North America.

The industry is expected to expand significantly in Europe in the near future. This is a result of an increase in the number of traffic accidents and a rise in the incidence of chronic diseases. Additionally, the rising number of government programs aimed at better healthcare and the surging public awareness of donation are projected to propel the market boom in Europe.

APAC is expected to develop at the highest rate during the projection period. This is primarily ascribed to an aging population, increasing prevalence of illnesses, existence of regional players, and government attempts to better the conditions of patients with hematologic disorders.

The industry in LATAM and the MEA is also expanding steadily due to their burgeoning healthcare industry. In addition, the volume of surgeries is rising proportionally to the increase in the incidence of chronic diseases in the region.

Top Plastic Blood Bag Manufactures Are:

• SB-KAWASUMI LABORATORIES INC.
• Neomedic International SL
• JMS Co. Ltd.
• AdvaCare Pharma
• Macopharma
• GenesisBPS
• Sichuan Nigale Biomedical Co. Ltd.
• Terumo Group

Market Size Breakdown by Segment

The report provides a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Type

• Single Blood Bags
• Double Blood Bags
• Triple Blood Bags
• Quadruple Blood Bags

Based on End User

• Hospitals
• NGOs
• Blood Banks
• Home Healthcare

Based on Distribution Channel

• Tender Sales
• Private Sales

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa